» Articles » PMID: 23382407

Imbalance of Renal Production Between 5-hydroxytryptamine and Dopamine in Patients with Essential Hypertension Complicated by Microalbuminuria

Overview
Journal Am J Hypertens
Date 2013 Feb 6
PMID 23382407
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Background: In the kidney, 5-hydroxytryptamine (5-HT) and dopamine (DA) are formed by the same enzyme, l-aromatic amino acid decarboxylase, but act on renal function and glomerular structure in an opposite direction. The present study was designed to explore whether rates of renal production of 5-HT relative to that of DA are altered in patients with essential hypertension and microalbuminuria.

Methods: We measured urinary levels of 5-HT and DA, reflecting renal production of 5-HT and DA as well as 24-hour ambulatory blood pressure and urinary albumin excretion in 82 consecutive untreated, essential hypertensives without overt proteinuria.

Results: Urinary 5-HT excretion and the ratio of urinary 5-HT to DA were significantly higher in 22 patients with microalbuminuria than in the remaining patients with normoalbuminuria, although urinary DA levels did not differ between the groups. The 24-hour systolic and diastolic blood pressures were also higher in the microalbuminuric group than in the normoalbuminuric group. Multiple regression analysis revealed that urinary 5-HT excretion and 24-hour systolic blood pressure were independently associated with urinary albumin excretion. Furthermore, urinary 5-HT excretion was positively correlated with creatinine clearance as well as blood pressure but tended to be negatively correlated with fractional excretion of sodium.

Conclusions: Renal production of 5-HT is enhanced compared with that of DA in essential hypertensives with microalbuminuria. This imbalance may contribute to the genesis of hypertensive glomerular damage.

Citing Articles

Dopamine in the Regulation of Glucose Homeostasis, Pathogenesis of Type 2 Diabetes, and Chronic Conditions of Impaired Dopamine Activity/Metabolism: Implication for Pathophysiological and Therapeutic Purposes.

Lisco G, De Tullio A, Iovino M, Disoteo O, Guastamacchia E, Giagulli V Biomedicines. 2023; 11(11).

PMID: 38001993 PMC: 10669051. DOI: 10.3390/biomedicines11112993.


Monoamino oxidase alleles correlate with the presence of essential hypertension among hypogonadic patients.

Royo J, Castellano-Castillo D, Ruiz-Galdon M, Molina-Vega M, Cardona F, Tinahones F Mol Genet Genomic Med. 2019; 8(1):e1040.

PMID: 31743621 PMC: 6978270. DOI: 10.1002/mgg3.1040.


Active Acupoints Differ from Inactive Acupoints in Modulating Key Plasmatic Metabolites of Hypertension: A Targeted Metabolomics Study.

Yang M, Yu Z, Chen X, Guo Z, Deng S, Chen L Sci Rep. 2018; 8(1):17824.

PMID: 30546033 PMC: 6292875. DOI: 10.1038/s41598-018-36199-1.


A Targeted Metabolomics MRM-MS Study on Identifying Potential Hypertension Biomarkers in Human Plasma and Evaluating Acupuncture Effects.

Yang M, Yu Z, Deng S, Chen X, Chen L, Guo Z Sci Rep. 2016; 6:25871.

PMID: 27181907 PMC: 4867614. DOI: 10.1038/srep25871.


A HPLC-Q-TOF-MS-based urinary metabolomic approach to identification of potential biomarkers of metabolic syndrome.

Yu Z, Ning Y, Yu H, Tang N J Huazhong Univ Sci Technolog Med Sci. 2014; 34(2):276-283.

PMID: 24710945 DOI: 10.1007/s11596-014-1271-7.